4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Veru Inc. (VERU) operates in the Biotechnology industry and is headquartered in Miami, United States with about 20 employees. Its market capitalization is roughly $45 million. In the fiscal year ended 2025-09-30, VERU reported $0M in revenue and ($23M) in net income.
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally.
Interactive charts & full statements →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $16M | $39M | — |
| Gross Profit | — | $6M | $8M | $31M | $48M |
| Operating Income (EBIT) | ($36M) | ($37M) | ($96M) | ($84M) | — |
| Net Income | ($23M) | ($38M) | ($93M) | ($84M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($7M) | ($5M) | ($8M) | ($8M) | ($9M) | — |
| Net Income | ($3M) | ($5M) | $2M | ($7M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $30M | $60M | $50M | $135M | — |
| Total Liabilities | $12M | $28M | $30M | $53M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VERU viewer.
About TickerBase · Data methodology & sources